Sleek product design and engaging smartphone app revolutionizes CPAP experience for the world’s 100 million sleep apnea sufferers
San Diego, April 25, 2017 – ResMed (NYSE: RMD) today unveiled its AirMini™, the world’s smallest CPAP machine – a game-changer for people with sleep apnea.
Achieving new heights in patient-centered innovation, AirMini packs ResMed’s clinically proven CPAP (continuous positive airway pressure) technology along with its comfort and ease-of-use features into a sleek, portable, pocket-sized device ideal for traveling. The AirMini is available with ResMed’s proprietary AutoSet™ functionality as well as an innovative, built-in humidification system for patient comfort.
AirMini weighs a mere 0.66 pounds (300 grams) and measures just 5.4 x 3.3 x 2 in (13.6 x 8.4 x 5.2 cm).
"The ResMed AirMini has redefined CPAP therapy – providing patients with peace of mind, knowing they can easily get ResMed-quality therapy wherever they are," said Mick Farrell, ResMed CEO. "CPAP is now more portable and accessible than ever before. I have been traveling all over the world with a prototype of the AirMini system, using AutoSet, humidification, and an AirFit™ P10 pillows mask, and it has changed my travel life. I am so excited to see that this technology is now available to many millions of sleep apnea patients."
In a recent survey, 65% of CPAP users said device size is the #1 reason they don’t take their CPAP every time they travel, breaking the cycle of adherence and exposing themselves to sleep apnea’s chronic effects: they stop breathing repeatedly throughout the night, unconsciously transitioning between moments of sleep suffocation and jolts of awakening to resume breathing. This may cause dangerous levels of daytime fatigue and raise the risk of developing other fatal conditions like type 2 diabetes and heart failure.
AirMini’s comfort and ease-of-use features are ideal for patients and for home medical equipment providers who will benefit from the device as a growth driver for their business:
- A phone app (iOS and Android) for patients to change comfort settings and track their own nightly usage data, a practice that’s shown to increase compliance and health outcomes
- Portable and convenient waterless humidification to maximize comfort, capturing a patient’s exhaled heat and moisture with a HumidX™ humidifier in the mask tube and redelivering it to them
- Compatibility with ResMed’s AirFit N20 nasal and F20 full face masks, easy for home medical equipment providers to fit on a wide range of patients (an unprecedented 99 and 97 percent of patients, respectively) as well as a special AirMini version of the award-winning AirFit P10 nasal pillows mask.
AirMini will be available to U.S. CPAP users through their home medical equipment (HME) providers. ResMed will take preorders from HMEs beginning on May 3, 2017, and AirMini will begin shipping by May 31. It will also be available at initial launch in Australia, Canada, Denmark, Finland, Germany, New Zealand, Spain and the United Kingdom, with other countries to follow.
Patient and Customer Testimonials
"As a healthcare professional and a person with sleep apnea, I am in love with the AirMini. Traveling with my CPAP machine has been a hassle, given its weight and size. I look forward to being able to carry my AirMini in my purse."–Vickie B., a CPAP user in Green Bay, Wisconsin
"There is huge demand for a CPAP that’s easier to travel with. Not only have my patients asked me for it, they already trust the therapy they get from ResMed, so I know AirMini is going to be hugely popular. It’ll benefit my patients as well as our business."–Samantha Romsos, respiratory therapist at HME Home Medical in Green Bay, Wisconsin.
For more information, including a product fact sheet, photos, patient and customer testimonials and scientific claims made above, please visit newsroom.resmed.com/airmini-press-kit
ResMed (NYSE: RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 2 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world’s best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries.
Participants in ResMed’s AirMini prelaunch evaluation program received gift cards in consideration of their time and product feedback.